Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Vaccine|January 27, 2009
A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain)Mark A Jacobson, Stuart P Adler, Elizabeth Sinclair, et al.Ophthalmology|May 10, 2005
Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapyDouglas A Jabs, Janet T Holbrook, Mark L Van Natta, et al.AIDS (London, England)|May 11, 2002
A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infectionMark A Jacobson, John Spritzler, Alan Landay, et al.Plos One|April 22, 2009
Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patientsMark A Jacobson, Dirk P Ditmer, Elizabeth Sinclair, et al.The Journal of Infectious Diseases|June 27, 2002
Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV diseaseMostafa A Nokta, Fiona Holland, Victor De Gruttola, et al.The Journal of Infectious Diseases|April 10, 2004
Results of a cytomegalovirus (CMV)-specific CD8+/interferon- gamma+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitisMark A Jacobson, Holden T Maecker, Patricia L Orr, et al.The Journal of Infectious Diseases|April 20, 2011
Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapyPeter W Hunt, Jeffrey N Martin, Elizabeth Sinclair, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 3, 2006
Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipientsMark A Jacobson, Elizabeth Sinclair, Barry Bredt, et al.Journal of Clinical Immunology|April 12, 2005
Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067Ronald D'Amico, Yijun Yang, Donna Mildvan, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infectionBarbara L Shacklett, Catherine A Cox, Máire F Quigley, et al.Pageof 4